Nanjing Pharmaceutical\'s 2021 Restricted Stock Incentive Plan reserves and grants part of the first stock release and listing announcement for the lifting of sales restrictions
Articles of Association of Nanjing Pharmaceutical Co., Ltd. (2024 Second Extraordinary General Meeting of Shareholders)
Legal Opinion of Beijing Jingtian Gongcheng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Nanjing Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Nanjing Pharmaceutical
Nanjing Pharmaceutical Co., Ltd. prospectus for issuing convertible corporate bonds and securities to unspecified targets (registration draft)
Nanjing Pharmaceutical\'s indicative announcement on convening the 2024 Second Extraordinary General Meeting of Shareholders
Nanjing Pharmaceutical\'s indicative announcement on applying for the issuance of convertible corporate bonds to unspecified targets to submit prospectus (registration draft)
Nanjing Pharmaceutical: Materials of the 2024 Second Extraordinary General Meeting of Shareholders of Nanjing Pharmaceutical
Materials of the 2024 Second Extraordinary General Meeting of Shareholders of Nanjing Pharmaceutical
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s announcement on approval of registration for the issuance of ultra-short-term financing notes
Announcement of Nanjing Pharmaceutical on approval of registration for the issuance of ultra-short-term financing notes
Nanjing Pharmaceutical: Notice of Nanjing Pharmaceutical on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Nanjing Pharmaceutical: Announcement of Resolutions of the 9th Interim Meeting of the Board of Directors of Nanjing Pharmaceutical
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s announcement on capital increase to the holding subsidiary Anhui Tianxing Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical: Nanjing Pharmaceutical Supervisory Board\'s inspection opinion on the Company\'s 2021 Restricted Stock Incentive Plan reserves and grants part of the first sales restriction period to lift the sales restriction list
Nanjing Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing Jingtian Gongcheng Law Firm on Nanjing Pharmaceutical Co., Ltd.\'s 2021 Restricted Stock Incentive Plan Reserve Grants Part 1 of the Achievements of Lifting the Conditions of Cancellation of the Sales Restriction Period
Nanjing Pharmaceutical: Full text of Nanjing Pharmaceutical\'s 2024 third quarter report
Nanjing Pharmaceutical: Announcement of Resolutions of the 9th Interim Meeting of the Supervisory Board of Nanjing Pharmaceuticals
Nanjing Pharmaceutical: Nanjing Pharmaceutical\'s announcement on the company\'s 2021 Restricted Stock Incentive Plan reserves and grants some of the first results to lift the sales restrictions during the period of lifting the sales restrictions
Nanjing Pharmaceuticals: Amendments to the Articles of Association
No Data
No Data